Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Whole-genome landscape of adult T-cell leukemia/lymphoma

Blood (2022) 139 (7): 967–982.

https://doi.org/10.1182/blood.2021013568

Published: 2022

Includes: Supplemental data

Journal Articles

CARD11 Mutation Induces Oligoclonal Expansion of T-Cells, and Accelerates ATL Development in Combination with HBZ

Takuro Kameda, MD PhD, Kotaro Shide, MD PhD, Ayako Kamiunten, MD, Tahira Yuki, Masaaki Sekine, MD, Keiichi Akizuki, MD, Tomonori Hidaka, MD, Yoko Kubuki, MD PhD, Midori Sugiyama, Daisuke Morishita, PhD, Kazuya Shimoda, MD PhD

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-142242

Published: 2020

Journal Articles

Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms in mice

Kotaro Shide, Takuro Kameda, Ayako Kamiunten, Yoshinori Ozono, Yuki Tahira, Takako Yokomizo-Nakano, Sho Kubota, Masaya Ono, Kazuhiko Ikeda, Masaaki Sekine, Keiichi Akizuki, Kenichi Nakamura, Tomonori Hidaka, Yoko Kubuki, Hisayoshi Iwakiri, Satoru Hasuike, Kenji Nagata, Goro Sashida, Kazuya Shimoda

Blood (2020) 136 (1): 106–118.

https://doi.org/10.1182/blood.2019003358

Published: 2020

Includes: Supplemental data

Journal Articles

The Role of Calreticulin in Normal Hematopoiesis and Neoplastic Hematopoiesis of Myeloproliferative Neoplasms

Kotaro Shide, MD PhD, Takuro Kameda, MD PhD, Ayako Kamiunten, MD, Yoshinori Ozono, MD, Yuki Tahira, MD, Masaaki Sekine, MD, Masaya Ono, MD PhD, Takako Yokomizo, PhD, Sho Kubota, Keiichi Akizuki, MD, Yoko Kubuki, MD PhD, Tomonori Hidaka, MD, Goro Sashida, MD PhD, Kazuya Shimoda, MD PhD

Blood (2019) 134 (Supplement_1): 309.

https://doi.org/10.1182/blood-2019-130034

Published: 2019

Journal Articles

Depletion of Neoplastic CD11b Positive Cells in Jak2 V617F Mutant Mice Reduced Fibrocytes in Bone Marrow and Improved Myelofibrosis

Yoshinori Ozono, MD, Kotaro Shide, MD PhD, Takuro Kameda, MD PhD, Ayako Kamiunten, MD, Yuki Tahira, MD, Masaaki Sekine, MD, Keiichi Akizuki, MD, Kenichi Nakamura, MD, Hisayoshi Iwakiri, MD, Tomonori Hidaka, MD, Yoko Kubuki, MD PhD, Satoru Hasuike, MD PhD, Fumiyo Toyoshima, MD PhD, Akira Sawaguchi, MD PhD, Kenji Nagata, MD PhD, Kazuya Shimoda, MD PhD

Blood (2019) 134 (Supplement_1): 310.

https://doi.org/10.1182/blood-2019-130042

Published: 2019

Journal Articles

TET2 Mutation Associated with Organ Infiltrations in ATLL

Takuro Kameda, MD, Kotaro Shide, MD PhD, Ayako Kamiunten, MD, Yuki Tahira, MD, Keiichi Akizuki, MD, Masaaki Sekine, MD, Tomonori Hidaka, MD, Yoko Kubuki, MD PhD, Michihiro Hidaka, MD PhD, Atae Utsunomiya, MD PhD, Takayuki Ohshima, Keisuke Kataoka, MD PhD, Seishi Ogawa, MD PhD, Kazuya Shimoda, MD PhD

Blood (2018) 132 (Supplement 1): 1345.

https://doi.org/10.1182/blood-2018-99-118065

Published: 2018

Journal Articles

Haploinsufficiency of CALR Confers Hematopoietic Stem Cells (HSCs) with a Clonal Advantage over Wild-Type Cells, and, in Setting of Myeloproliferative Neoplasms, Compensates for the Functions of HSCs Impaired By the Calr Mutation

Kotaro Shide, MD PhD, Takuro Kameda, MD, Ayako Kamiunten, MD, Masaaki Sekine, MD, Yoshinori Ozono, MD, Takako Yokomizo, PhD, Keiichi Akizuki, MD, Yuki Tahira, MD, Yoko Kubuki, MD PhD, Tomonori Hidaka, MD, Goro Sashida, MD PhD, Kazuya Shimoda, MD PhD

Blood (2018) 132 (Supplement 1): 97.

https://doi.org/10.1182/blood-2018-99-114304

Published: 2018

Journal Articles

Mogamulizumab for ATLL in Clinical Practice

Masaaki Sekine, MD, Masaki Takeuchi, MD, Takanori Toyama, MD, Kouichi Maeda, MD, Seiichi Sato, MD, Kiyoshi Yamashita, MD, PhD, Junzo Ishizaki, MD, Akizuki Keiichi, MD, Ayako Kamiunten, MD, Takuro Kameda, MD PhD, Kotaro Shide, MD PhD, Tomonori Hidaka, MD, Yoko Kubuki, MD PhD, Akira Kitanaka, MD PhD, Kazuya Shimoda, MD, PhD

Blood (2016) 128 (22): 2998.

https://doi.org/10.1182/blood.V128.22.2998.2998

Published: 2016

Journal Articles

Physiological Expression of Calr Mutant Increases Cell Growth and Cytokine Independency in Human Cell Lines Expressing Mpl, and Develops Essential Thrombocythemia in Mice

Kotaro Shide, MD PhD, Takuro Kameda, MD PhD, Masaaki Sekine, MD, Ayako Kamiunten, MD, Keiichi Akizuki, MD, Yuki Tahira, MD, Tomonori Hidaka, MD, Yoko Kubuki, MD PhD, Arata Honda, PhD, Akira Sawaguchi, MD PhD, Akira Kitanaka, MD PhD, Kazuya Shimoda, MD, PhD

Blood (2016) 128 (22): 954.

https://doi.org/10.1182/blood.V128.22.954.954

Published: 2016

Journal Articles

Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator

Blood (2015) 125 (2): 304–315.

https://doi.org/10.1182/blood-2014-04-555508

Published: 2015

Includes: Supplemental data

Journal Articles

Therapies Targeting the MAPK Pathway Improve Bone Marrow (BM) Fibrosis Induced By JAK2V617F

Kotaro Shide, MD PhD, Takuro Kameda, MD, Ayako Kamiunten, MD, Masaaki Sekine, MD, Keiichi Akizuki, MD, Haruko Shimoda, MD PhD, Tomonori Hidaka, MD PhD, Yoko Kubuki, MD, Akira Kitanaka, MD PhD, Kazuya Shimoda, MD PhD

Blood (2014) 124 (21): 162.

https://doi.org/10.1182/blood.V124.21.162.162

Published: 2014

Journal Articles

Prognostic Factor, Including Relative Dose Intensity, For Adult T-Cell Leukemia/Lymphoma In Clinical Practice

Ayako Kamiunten, Akira Kitanaka, MD, PhD, Yoko Kubuki, Tomonori Hidaka, Kotaro Shide, MD, PhD, Takuro Kameda, MD, Masaaki Sekine, Kiyoshi Yamashita, Hitoshi Matsuoka, Hiroshi Kawano, Takanori Toyama, Seiichi Satou, Kouichi Maeda, Junzo Ishizaki, Kazuya Shimoda, MD, PhD

Blood (2013) 122 (21): 1799.

https://doi.org/10.1182/blood.V122.21.1799.1799

Published: 2013

Journal Articles

Impact Of TET2 Deficiency On MPN Harboring JAK2V617F Mutation

Takuro Kameda, MD, Kotaro Shide, MD, PhD, Masaaki Sekine, Ayako Kamiunten, Tomonori Hidaka, Yoko Kubuki, Akira Kitanaka, MD, PhD, Kousuke Marutsuka, Kazuya Shimoda, MD, PhD

Blood (2013) 122 (21): 478.

https://doi.org/10.1182/blood.V122.21.478.478

Published: 2013

Journal Articles

TET2 Is Essential for Survival in Mice, and Decreased TET2 Expression Enlarges HSC Compartment and Alters Cell Differentiation

Kotaro Shide, MD, PhD, Takuro Kameda, MD, Haruko Shimoda, MD, PhD, Ayako Kamiunten, Masaaki Sekine, Tomonori Hidaka, Keiko Katayose, Yoko Kubuki, Akira Kitanaka, Kazuya Shimoda, MD, PhD

Blood (2011) 118 (21): 2471.

https://doi.org/10.1182/blood.V118.21.2471.2471

Published: 2011

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Whole-genome landscape of adult T-cell leukemia/lymphoma

CARD11 Mutation Induces Oligoclonal Expansion of T-Cells, and Accelerates ATL Development in Combination with HBZ

Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms in mice

The Role of Calreticulin in Normal Hematopoiesis and Neoplastic Hematopoiesis of Myeloproliferative Neoplasms

Depletion of Neoplastic CD11b Positive Cells in Jak2 V617F Mutant Mice Reduced Fibrocytes in Bone Marrow and Improved Myelofibrosis

TET2 Mutation Associated with Organ Infiltrations in ATLL

Haploinsufficiency of CALR Confers Hematopoietic Stem Cells (HSCs) with a Clonal Advantage over Wild-Type Cells, and, in Setting of Myeloproliferative Neoplasms, Compensates for the Functions of HSCs Impaired By the Calr Mutation

Mogamulizumab for ATLL in Clinical Practice

Physiological Expression of Calr Mutant Increases Cell Growth and Cytokine Independency in Human Cell Lines Expressing Mpl, and Develops Essential Thrombocythemia in Mice

Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator

Therapies Targeting the MAPK Pathway Improve Bone Marrow (BM) Fibrosis Induced By JAK2V617F

Prognostic Factor, Including Relative Dose Intensity, For Adult T-Cell Leukemia/Lymphoma In Clinical Practice

Impact Of TET2 Deficiency On MPN Harboring JAK2V617F Mutation

TET2 Is Essential for Survival in Mice, and Decreased TET2 Expression Enlarges HSC Compartment and Alters Cell Differentiation

Email alerts

ASH Publications

American Society of Hematology